Literature DB >> 16937070

Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.

Feng-Cheng Liu1, Chen-Hung Chen, Tsu-Yi Chao.   

Abstract

Polymyositis may occur along with other manifestations of chronic graft vs host disease after allogeneic bone marrow transplantation (BMT). Donor lymphocyte infusion (DLI) could produce durable remissions in relapsed patients with chronic myelogenous leukemia (CML) but it may contribute to the development of polymyositis. We report in this study a 25-year-old man who suffered from a relapse of CML 4 years after a sibling human leukocyte antigen-matched allogenic BMT. The patient developed polymyositis 18 months after DLI. Mini-pulse therapy with methylprednisolone was effective for his proximal weakness and elevated creatine phosphokinase. There was no relapse of symptoms of polymyositis on tapering of the medication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937070     DOI: 10.1007/s10067-006-0346-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  14 in total

Review 1.  Speculations on mechanisms of HLA associations with autoimmune diseases and the specificity of "autoreactive" T lymphocytes.

Authors:  E Möller; J Böhme; M A Valugerdi; A Ridderstad; O Olerup
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

2.  Chronic graft versus host disease presenting with polymyositis.

Authors:  N Pier; V Dubowitz
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-25

3.  Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT).

Authors:  Y Oshima; S Takahashi; H Nagayama; K Nishiwaki; Y Kobayashi; A Tojo; S Okamoto; K Tani; K Ozawa; T Wakabayashi; N Sato; S Kobayashi; K Nakamura; Y Ohya; N Nukina; I Kanazawa; S Asano
Journal:  Bone Marrow Transplant       Date:  1997-04       Impact factor: 5.483

Review 4.  Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

Authors:  D R Couriel; G Z Beguelin; S Giralt; M De Lima; C Hosing; M A Kharfan-Dabaja; A Anagnostopoulos; R Champlin
Journal:  Bone Marrow Transplant       Date:  2002-10       Impact factor: 5.483

5.  Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

Authors:  M Sykes; F Preffer; S McAfee; S L Saidman; D Weymouth; D M Andrews; C Colby; R Sackstein; D H Sachs; T R Spitzer
Journal:  Lancet       Date:  1999-05-22       Impact factor: 79.321

6.  Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion.

Authors:  L Silberstein; A Davies; S Kelsey; J Foran; C Murrell; D D'Cruz; S Vinnicombe; A Norton; J Cavenagh
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

7.  Graft-versus-leukemia reactions after bone marrow transplantation.

Authors:  M M Horowitz; R P Gale; P M Sondel; J M Goldman; J Kersey; H J Kolb; A A Rimm; O Ringdén; C Rozman; B Speck
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

8.  Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.

Authors:  B Leber; I R Walker; A Rodriguez; J A McBride; R Carter; M C Brain
Journal:  Bone Marrow Transplant       Date:  1993-10       Impact factor: 5.483

9.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Authors:  H J Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; D Niederwieser; F van Rhee; J Mittermueller; T de Witte; E Holler; H Ansari
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

10.  Myositis of chronic graft versus host disease.

Authors:  M G Reyes; P Noronha; W Thomas; R Heredia
Journal:  Neurology       Date:  1983-09       Impact factor: 9.910

View more
  2 in total

1.  Neuromuscular complications after hematopoietic stem cell transplantation.

Authors:  Susanne Koeppen; Abhiyrahmi Thirugnanasambanthan; Michael Koldehoff
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

2.  Polymyositis after donor lymphocyte infusion.

Authors:  Juan Montoro; Juan Carlos Hernández-Boluda; Cristina Arbona; Carlos Solano
Journal:  Int J Hematol       Date:  2012-08-19       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.